Filing Details
- Accession Number:
- 0001209191-14-026994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-10 16:20:13
- Reporting Period:
- 2014-04-08
- Filing Date:
- 2014-04-10
- Accepted Time:
- 2014-04-10 16:20:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337798 | Bradley G Cole | 301 Penobscot Drive Redwood City CA 94063 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-08 | 3,000 | $2.88 | 25,226 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-08 | 3,000 | $27.00 | 22,226 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-04-08 | 3,000 | $0.00 | 3,000 | $2.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,337 | 2014-12-02 | No | 4 | M | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2013.
- Represents actual sale price.
- Includes an aggregate of 12,655 shares of common stock issuable pursuant to previously reported restricted stock unit awards that have not vested.
- The option became exercisable as to 25% of the shares on December 2, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.